The AcroImaging Algorithm
An imaging pathway for management of somatotroph tumors in acromegaly
Thank you for visiting acroimaging.com. This website hosts a hierarchical imaging algorithm for patients with somatotroph tumors, which incorporates advanced anatomical as well as molecular (functional) imaging. The full reasoning behind this algorithm is elaborated in a joint publication between the Cambridge Endocrine Molecular Imaging Group and the Charité – Universitätsmedizin Berlin Department of Endocrinology and Metabolism. For further information, we suggest reading the full publication:
(URL to be added)
Important Qualifier:
The decision support tool offered on this website is intended solely for medical professionals. It is designed to aid in the process of selecting appropriate imaging modalities for patients with acromegaly. It is essential to acknowledge that this algorithm has not undergone validation through rigorous clinical trials. Therefore, it should be considered as a supplementary resource and not a definitive or standalone diagnostic tool.
It is not intended to replace professional judgment but rather to complement and support the decision-making process. The creators and operators of this website disclaim any liability for the consequences of decisions made based on the information provided by the decision support tool.
By proceeding to use this decision support tool, you agree to accept its limitations and confirm that you will integrate its output into your clinical decision-making process responsibly and in accordance with professional standards.
Pituitary Tumor Centers of Excellence (PTCOE)
For further information on Pituitary Tumor Centers of Excellence, we recommend reading the following publications:
Validation of criteria for defining Pituitary Tumors Centers of Excellence (PTCOE) – Abstract – Europe PMC
Criteria for the definition of Pituitary Tumor Centers of Excellence (PTCOE): A Pituitary Society Statement | SpringerLink